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The effects of Streptococcus thermophilus on ceramide
levels either in vitro on cultured human keratinocytes
or in vivo on stratum corneum, have been investi-
gated. In vitro, Streptococcus thermophilus enhanced the
levels of ceramides in keratinocytes in a time-
dependent way. The presence of high levels of
neutral, glutathione-sensitive, sphingomyelinase in
Streptococcus thermophilus could be responsible for the
observed ceramide increase. The application of a
base cream containing sonicated Streptococcus thermo-
philus in the forearm skin of 17 healthy volunteers for
7 d also led to a significant and relevant increase of
skin ceramide amounts, which could be due to the
The normal morphology of stratum corneum is essentialfor maintaining the water barrier of the skin (Bowserand White, 1985; Rawlings et al, 1994). The protein-enriched corneocytes are embedded in an intercellularlipid matrix which is composed primarily of ceramides
(43–46% of total lipids), cholesterol, and fatty acids together with
smaller amounts of cholesterol sulfate, glucosylceramides, and
phospholipids (Yardley and Summerly, 1981; Elias et al, 1988).
These lipids form multilamellar sheets within the intercellular spaces
of the stratum corneum, the organization of which is essential in
maintaining the functionality of the skin as an effective barrier to
water loss (Rougier et al, 1983; Eckert and Rorke, 1989; Potts and
Francoeur, 1991). In addition, they also play an important part in
determining the mechanical, cohesive, and desquamatory properties
of the stratum corneum, and therefore have a key role to counteract
the environmental challenges which can lead to disturbances in
skin function (for a review see Rawlings et al, 1994). A global
decrease in lipid content leads to alterations in lamellar bilayer
morphology which appear to underlie the impaired functional
abnormalities commonly associated with aging. Indeed, an age-
related decline in stratum corneum ceramide, cholesterol, and fatty
acid levels has been previously reported (Ghadially et al, 1995;
Rogers et al, 1996). Overall, the total lipid levels decrease by
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sphingomyelin hydrolysis through bacterial neutral
sphingomyelinase. Indeed, similar results were
obtained with a base cream containing purified bac-
terial neutral sphingomyelinase. In addition, the inhibi-
tion of bacterial neutral sphingomyelinase activity
through glutathione blocked the skin ceramide increase
observed after the treatment. The topical application
of a sonicated Streptococcus thermophilus preparation,
leading to increased stratum corneum ceramide levels,
could thus result in the improvement of lipid barrier
and a more effective resistance against xerosis. Key
words: HaCat cells/lactobacillus/skin/sphingomyelinase.
J Invest Dermatol 113:98–106, 1999
approximately 30%, which may reflect the slower keratinocyte
metabolism of the aged (Grove and Kligman, 1983), leading to
decreased biosynthetic capacity. Recently, a study demonstrated a
seasonal-related reduction in stratum corneum lipid levels probably
reflecting decreased epidermal lipid biosynthesis (Rogers et al,
1996). Apart from the increased susceptibility of the barrier to
damage in the elderly, the reduction in lipid levels could explain
the increased incidence of xerosis in winter (Rogers et al, 1996).
The reduction in lipid levels may in turn reduce the water content
of the stratum corneum. This may influence the activity of the
stratum corneum proteases thought to be involved in desquamation
(Lundstrom and Egullrud, 1990; Egelrud, 1993; Rawlings et al,
1994) and interferes with the generation of natural moisturizing
factors (Scott and Harding, 1986), leaving the stratum corneum
more susceptible to xerosis. The reduction of the stratum corneum
ceramide levels have been proposed as a possible etiologic factor
in atopic dermatitis and psoriasis (Motta et al, 1994; Murata et al,
1996). Moreover, topical application of ceramides has been shown
to improve directly the barrier function of the stratum corneum
(Imokawa et al, 1989). Epidermis possesses the capacity to synthesize
all lipids required for the barrier formation. Especially unique for
the epidermis is the synthesis of large amounts of glucosylceramides
and ceramides (Heldberg et al 1988), which has also been demon-
strated in organotypic keratinocyte cultures (Schurer et al, 1989;
Madison et al, 1990). The amount of ceramide in the stratum
corneum is regulated by the balance among the ceramide-generating
enzymes including serine-palmitoyltransferase (Holleran et al, 1991),
sphingomyelinase (SMase) (Menon et al 1986; Yamamura and
Tezuka, 1990), and β-glucocerebrosidase (Holleran et al, 1992) and
the degradative enzyme ceramidase (Yada et al 1995). Cultured
keratinocytes were reported to have a high level of serine palmitoyl-
transferase activity, which catalyzes the synthesis of the long-chain
base precursor of sphingolipids (Holleran et al, 1990). Moreover,
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the activity of ceramide glucosyltransferase, the enzyme responsible
for glucosyl-ceramide synthesis in cultured human keratinocytes,
has been recently studied and characterized (Sando et al 1996).
Both sphingomyelin (SM) and SMase, which hydrolyzes SM into
ceramides, are present in the epidermis and are originally contained
in lamellar bodies (Bowser and Gray, 1978; Yardley and Summerly,
1981). An altered SM metabolism in the skin of patients with
atopic dermatitis, which has been attributed to a deficient function
of SMase and a parallel abnormal expression of SM acylase, has
been reported; this could explain the ceramide deficiency and the
marked vulnerability of the atopic skin to irritants or allergens
(Murata et al, 1996). Moreover, recent reports suggest that the skin
of patients with atopic dermatitis is colonized by ceramidase-
secreting bacteria (i.e., Pseudomonas aeruginosa and/or related strains)
and correlate the deficiency of ceramide in the horny layer of
epidermis and the associated impairment of the barrier permeability
with the presence of this ceramide-degradative enzyme (Okino
et al, 1998; Ohnishi et al, 1999). Interestingly, Rawlings et al (1996)
have reported the induction of a ceramide level enhancement
either in keratinocytes in vitro and in skin in vivo, which was
associated with an increased stratum corneum barrier and an
increased effect in resisting skin xerosis. The authors hypothesized
that lactic acid could be metabolized to acetate which in turn is
used for ceramide biosynthesis in keratinocytes.
Taken together, these findings strongly indicate that skin treat-
ment with exogenous factors capable of increasing the levels of
stratum corneum lipids, mainly ceramides, may improve barrier
function and stratum corneum flexibility; consequently this may
slow down, in healthy subjects, the skin aging process and offer
advantages for patients with skin conditions due to a defective
synthesis of lipids.
As many bacteria possess high levels of SMase in their membrane,
they may be particularly useful in inducing an increase of skin
ceramide generation through SM hydrolysis. SM represents one of
the most important lipid components of the mammalian plasma
membrane and is preferentially localized in the external outleaf
thus being readily available for its hydrolysis through an exogenous
source of SMase, such as bacterial SMase. Indeed, bacterial SMase
often has been used for the depletion of SM in a variety of cellular
systems leading to the release of ceramide (Bettaieb et al, 1996;
Wright et al 1996; Flamigni et al, 1997; Zhang et al, 1997).
Lactic acid bacteria are a group of bacteria belonging to a diverse
genera used to bring about milk fermentation, and composed chiefly
of bacteria whose primary metabolic end-product of carbohydrate
metabolism is lactic acid; this in turn preserves milk by providing
the acidity necessary for a tart flavor and for changes in the structure
of casein to achieve syneresis and desired functional characteristics
(Sanders, 1992; Johnson and Steele, 1997). Streptococcus salivarium
subspeciem thermophilus belongs to this group of bacteria and is
used to bring about the fermentation of several dairy products,
mainly cheeses and yogurt (Sanders, 1992; Johnson and Steele,
1997) and does not form a constituent of normal skin resident
microflora (James and Roth, 1992).
The aim of this work was to assess the possibility of increasing
ceramide levels either in vitro on cultured keratinocytes or in vivo
on stratum corneum by treatment with a sonicated preparation of
Streptococcus salivarium subspeciem thermophilus.
Our results indicate thatS. thermophilus treatment led to a significant
increase in ceramide levels both in vitro and in vivo. If we consider
that ceramides can maintain skin integrity, it is possible that topical
administration of S. thermophilus (as a source of exogenous SMase
able to hydrolyze skin SM) may consequently generate ceramide and
phosphorylcholine, possibly leading to an improvement in barrier
function and maintenance of stratum corneum flexibility; all these
events may help the stratum corneum resist xerosis.
MATERIALS AND METHODS
In vitro studies
Cell culture The spontaneously immortalized human keratinocyte cell line
HaCat (Boukamp et al, 1988) was a gift from Dr. Diana Boraschi (Dompe`
Research Center, L’Aquila, Italy). Cells were grown in plastic culture
dishes (Nunc, Wiesbaden, Germany) containing Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum,
2 mM L-glutamine, 100 units penicillin per ml, 50 µg streptomycin per
ml, and 50 µg gentamycin per ml. Media and culture reagents were
obtained from Gibco (Berlin, Germany), penicillin, streptomycin, and
gentamycin from Boehringer (Mannheim, Germany). Confluent cells were
subcultured every 3 d after detaching the cells with a 0.1% trypsin/
0.02% ethylenediamine tetraacetic acid solution. For the duration of the
experiments, HaCaT cells were maintained in serum-free keratinocyte
basal medium.
Preparation of bacterium suspensions Streptococcus thermophilus (strain S244),
cultivated in 10% skimmed milk sterilized at 110°C for 30 min with 0.1%
yeast extract, was obtained from Centro Ricerche YOMO (Milan, Italy),
in a pure lyophilized form (10 cfu per g). Stocks of 1.7 g lyophilized S.
thermophilus were resuspended in 5 ml phosphate-buffered solution (PBS),
sonicated (3 min and 50 s, alternating 10 s sonication and 10 s pause) with
a Vibracell sonicator (Sonic and Materials, Danbury, CT). For the in vitro
experiments, sonicated bacterium suspension was added to keratinocyte
cultures at 50 mg per 5 3 106 cells per 10 ml (final concentration). For
the topical applications, the sonicated bacteria (1.7 g per 5 ml) were mixed
with 20 ml of a base cream (Avant Garde, Sigma Tau, Pomezia, Rome,
Italy). A base cream containing purified neutral SMase (nSMase) from
Becillus cereus (Sigma) (4 ng per 50 µl PBS per ml base cream) was also
prepared. Where indicated, bacterial extracts were preincubated for 60 min
with 5 mM glutathione (GSH, Calbiochem) before addition to the cream.
The GSH-containing creams were prepared immediately before use.
SMase assay in S. thermophilus Ten milligrams of lyophilized S. thermo-
philus were resuspended in 500 µl HEPES buffer 20 mM pH 7.4
containing 10 mM MgCl2, 2 mM ethylenediamine tetraacetic acid,
5 mM dithiothreitol, 0.1 mM Na3VO4, 0.1 mM Na2MoO4, 30 mM
p-nitrophenylphosphate, 10 mM β-glycerophosphate, 750 µM adenosine
triphosphate (ATP), 1 mM phenylmethylsulfonyl fluoride, 10 µM leupeptin,
10 µM pepstatin (Sigma), and 0.2% Triton X-100 (for the assay of nSMase)
or 500 µl of 0.2% Triton X-100 [for the assay of acidic SMase (aSMase)]
and sonicated as described above. Protein concentration was determined
through the Pierce Micro BCA assay kit, with bovine serum albumin
standards. For the assay of nSMase, different amounts of bacteria were
incubated for 2 h at 37°C in HEPES buffer 20 mM pH 7.4 containing
1 mM MgCl2, and [N-methyl-14C]sphingomyelin (SM) (0.28 µCi per ml,
specific activity 47 mCi per mmol; Amersham, Bucks., U.K.). The reaction
was initiated by the addition of 40 µl of labeled SM, previously dried,
resuspended in the assay buffer containing 3% Triton X-100, and solubilized
by short bursts of sonication and vortexed. For the assay of aSMase,
different amounts of sonicated bacteria were incubated for 2 h at 37°C in
a buffer (200 µl final volume) containing 250 mM sodium acetate, 1 mM
ethylenediamine tetraacetic acid, pH 5.0, and 40 µl of [N-methyl-14C]SM.
Where indicated, the bacterial extracts were preincubated for 60 min with
5 mM GSH to inhibit nSMase activity, as previously described (Liu and
Hannun, 1997; Liu et al, 1998). The reaction was stopped by the addition
of 250 µl chloroform/methanol (2/1, by vol). The phospholipids were
extracted by the addition of 800 µl chloroform/methanol (2/1, by vol),
and 250 µl of H2O. After centrifugation at 10 978 3 g for 15 min at 4°C,
the aqueous phase was extracted again twice more with 500 µl chloroform.
The organic phase, obtained in the different extraction steps, were collected
and washed once with 1 ml chloroform/methanol/water (3/48/47, by
vol), to remove totally free radioactive phosphorylcholine. The aqueous
phases were collected, transferred to scintillation vials, and routinely counted
by liquid scintillation counting. The counts per min represented the choline
phosphate generated from SM hydrolysis. Correspondingly, the organic
phase was analyzed on thin-layer chromatography (TLC) plates by using
chloroform/methanol/ammonia hydroxide [7 M]/water (85/15/0.5/0.5,
by vol). The hydrolysis of SM was quantitated by autoradiography and
liquid scintillation.
Ceramide measurement (diacylglycerol kinase assay) Subconfluent keratinocytes
were incubated in the presence or absence of sonicated S. thermophilus
(50 mg per 5 3 106 cells per 10 ml) at different times (0.25–18 h). After
incubation, the cells were washed twice with ice-cold PBS (pH 7.2),
resuspended in Tris/HCl buffer 20 mM pH 7.4, and harvested using a cell
lifter (Costar, Cambridge, MA). The number of cells collected after the
culture was not influenced by the presence of sonicated bacteria. After
freeze-drying, the cells were sonicated (1 min and 50 s, alternating 10 s
sonication and 10 s pause) and the protein concentration was determined
using the Micro BCA protein assay reagent kit (Pierce, Rockford, IL),
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with bovine serum albumin standards. No significant differences in protein
content were observed among control and treated cells. For the lipid
extraction, 400 µl of methanol, 500 µl of chloroform, and 200 µl of water
were added. Samples were stirred for 2 min on a vortex-mixer and
centrifuged at 10 978 3 g for 10 min. The extraction and centrifugation
steps were repeated twice. Lipids, previously dried under nitrogen, were
then incubated with Escherichia coli diacylglycerol kinase (DAG kinase assay
kit and 32P-ATPγ, specific activity 3 Ci per mmol, Amersham) according
to the manufacturer’s instructions and applied to silica gel TLC plates using
a TLC applicator (Camag, Berlin, Germany). Ceramide phosphate was
then resolved using CHCl3/CH3OH/CH3COOH (65/15/5, vol/vol/vol)
as solvent. Authentic ceramides from bovine brain (ceramide type III,
nonhydroxy fatty acid ceramides; and ceramide type IV, hydroxy fatty acid
ceramides; Sigma) were identified by autoradiography at Rf 5 0.25 and
Rf 5 0.11, respectively. Specific radioactivity of ceramide-1-phosphate
was determined by scintillation counting of corresponding spots scraped
off the gel. Quantitative results for ceramide production were obtained by
comparing the experimental values with a linear curve of the ceramide
standards and are expressed as picomoles of ceramide-1-phosphate per
100 µg protein.
[N-Methyl-14C]choline labeling Subconfluent HaCaT cells were incu-
bated with pulse medium (DMEM containing 0.5 µCi [N-methyl-14C]
choline per ml; Amersham; 55 mCi per mol) for 48 h at 37°C. The cells
were then washed twice and cultured (5 3 106 cells per 10 ml) for 18 h
with fresh medium in the presence or absence of sonicated S. thermophilus
(50 mg per 10 ml, final concentration). After incubation, the cells were
washed twice with ice-cold PBS (pH 7.2), resuspended in Tris/HCl buffer
20 mM pH 7.4, and harvested as described above. After lipid extraction,
the organic phases, obtained from different extraction steps were collected,
washed once with 1 ml of the solvent system containing chloroform/
methanol/water (3/48/47, by vol), dried under nitrogen, and finally
resuspended in 110 µl chloroform. Then, 10 µl aliquots of the chloroform
phase were taken for scintillation counting and 100 µl were applied to
silica gel TLC plates. Lipids were separated using chloroform/methanol/
acetic acid/water (100/60/20/5, by vol) as the solvent system. Unlabeled
lyso-phosphatidylcholine, SM, and phosphatidylcholine (Sigma) were used
as standards and visualized in iodine vapor (Rf 5 0.1, 0.26, and 0.6,
respectively). Radioactive spots were visualized by autoradiography, scraped
from the plate and counted by liquid scintillation.
Ceramide synthase assay Assay of ceramide synthase activity was performed
as previously described (Bose et al, 1995). After treatment with sonicated
S. thermophilus suspension, keratinocytes, collected (as described above),
were resuspended in 300 µl of homogenization buffer (25 mM HEPES
pH 7.4, 5 mM ethyleneglycol-bis(β-aminoethyl ether)-N,N,N9,N9-tetra-
acetic acid, 50 mM NaF, 10 µg leupeptin per ml, and 10 µg soybean trypsin
inhibitor per ml), disrupted by sonication, and lysates were centrifuged at
800 3 g for 5 min. Protein concentrations in the postnuclear supernatants
were determined through the Micro BCA protein assay reagent kit (Pierce),
with bovine serum albumin as the standard. Seventy-five microgram
proteins were incubated in a 1 ml reaction mixture containing 2 mM
MgCl2, 20 mM HEPES (pH 7.4), 20 µM defatted bovine serum albumin
(Sigma), 20 µM dihydrosphingosine, 70 µM unlabeled palmitoyl-coenzyme
A, and 3.6 µM (0.2 µCi) [1-14C]palmitoyl-coenzyme A (55 mCi per
mmol; Amersham). Dihydrosphingosine was dried under nitrogen from a
stock solution in 100% ethanol and dissolved with sonication in the reaction
mixture prior to addition of cell extracts. The reaction was started by
addition of palmitoyl-coenzyme A, incubated at 37°C for 1 h, and then
stopped by extraction of lipids using 2 ml of chloroform/methanol (1/2,
by vol). The lower phase was removed, concentrated under nitrogen, and
applied to a silica gel 60 TLC plate. Dihydroceramide was resolved from
free radiolabeled fatty acid using a solvent system of chloroform/methanol/
3.5 M ammonium hydroxide (85/15/1), identified by autoradiography
based on comigration with ceramide standards (stained with iodine vapor),
and quantitated by liquid scintillation counting. The amount of palmitoyl-
CoA consumed did not exceed 5% of total.
Cholesterol level assay To analyze cholesterol levels, lipids were extracted
(as described above) from keratinocytes previously incubated in the absence
or presence of S. thermophilus extract for 1, 6, or 18 h. TLC were developed
with chloroform/methanol/acetic acid/water (50/37.5/3.5/2, by vol) to
resolve and quantitate cholesterol. Authentic standards were chromato-
graphed in parallel. After solvent development, the chromatograms were
air-dried, sprayed with 10% CuSO3, 8% H3PO4 aqueous solution and
charred on a 180°C hot plate. The charred lipids were quantitated by
photodensitometry (BIORAD GS-670, Imaging densitometer).
In vivo studies
Healthy volunteers, treatment and sample collection The study was conducted
as a double-blind paired-comparison study, with treatment regimens
randomized and balanced to a group of 17 healthy Caucasian volunteer
subjects (people from our laboratories; male and female, ages 24–47 y). All
the subjects had normal skin as judged by visual assessment. Subjects first
completed a 4 d washout phase, during which they were required to use
a mild soap bar for general cleansing and apply no moisturizers, or any
other products, to their forearms. These requirements persisted throughout
the study. During the 1 wk application phase, 0.5 g of test product was
applied twice daily to the volar surface of the forearms. Each subject
applied an ‘‘active’’ formulation (base cream as vehicle containing S.
thermophilus) to one forearm and the vehicle alone to the contralateral
forearm. Some volunteers were treated in different forearm areas with a
base cream containing purified nSMase from B. cereus (Sigma) (4 ng per
50 µl PBS per ml base cream). Samples of stratum corneum were collected
with a noninvasive procedure for topical lipid extraction from the volar
aspect of the forearms, as previously described (Lavrijsen et al, 1994), before
(T0) or after (T1) the topical application. Briefly, the topical extraction
protocol comprised two consecutive extractions with 10 ml solvent solution
(acetone/diethylether, 1/1, by vol), the first extraction for 5 min, the
second for 25 min. The solution was applied using a glass tube of cross-
sectional area 7 cm2, precleaned in chloroform/methanol and having a
simple flat edge without any lining material. The tube was held in position
manually on the extraction site with a force sufficient to prevent lateral
leakage. To remove contamination with squames the extracts were centri-
fuged (800 3 g). Only the second fraction was used for further analysis;
the first extract was used to remove sebaceous and exogenous lipids from
the stratum corneum. The supernatants were concentrated in a rotary
evaporator (Savant Instruments Inc., Holbrook, NY), evaporated to dryness
in glass tubes under a stream of nitrogen and the residues were dissolved
in 1 ml chloroform/methanol (9/1, by vol) and stored at –20°C until use.
Analysis of stratum corneum ceramides The lipid extracts obtained (as
described above) were evaporated under nitrogen and reconstituted in
chloroform (200 µl). An aliquot of extracted lipids was incubated with E.
coli diacylglycerol kinase (DAG kinase assay kit, Amersham) and 32P-ATPγ
(specific activity 3 Ci per mmol; Amersham) to determine the levels of
ceramide (as described above). To normalize the lipid extracts and to allow
interperson comparisons in the in vivo studies, the mass of each lipid
fraction was normalized to the amount of stratum corneum proteins.
Detergent-soluble proteins of the pelleted corneocytes were extracted with
protein solubilization buffer (20 mM β-mercaptoethanol in 10 mM sodium
phosphate buffer, pH 7.2, with 1% sodium dodecyl sulfate) for 2 h at 60°C
with vortexing at 1 and 2 h and then centrifuged at 573 3 g for 5 min to
pellet undissolved material. Stratum corneum proteins were assayed using
the Pierce Micro BCA assay kit (Pierce). Quantitative results for ceramide
production are expressed as picomoles of ceramide-1-phosphate per microg-
ram of stratum corneum proteins.
Statistical analysis For in vitro data analysis, the Student’s t test was
performed by the STATPAC Computerized Program, and p , 0.05 was
used as the significance criterion. For in vivo data analysis, the differences
between the results obtained with the control cream treatment and those
obtained with the experimental cream treatment were tested by using the
t test for paired data.
RESULTS
In vitro studies
nSMase in S. thermophilus To assess the presence of SMase in S.
thermophilus, the activities of both acidic and nSMase were assayed
by using different amounts of sonicated bacteria in appropriate
buffers containing [14C]SM (as described in Materials and Methods).
The results reported in Fig 1 show the presence of high levels of
nSMase in sonicated S. thermophilus. The percentage of SM hydro-
lysis gradually decreased by reducing the amounts of bacteria, which
was as expected. On the other hand, no presence of aSMase was
detected in bacterial samples (not shown). Considering that nSMase
activity could be inhibited by GSH (Liu and Hannun, 1997; Liu
et al, 1998), we analyzed the effect of GSH on bacterial nSMase
in vitro. The preincubation for 60 min of the bacterial extracts with
GSH (5 mM) strongly reduced (80–90% inhibition) the SM
hydrolysis. Similar results were obtained with purified nSMase from
B. cereus. The SMase activity was also analyzed through the
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Figure 1. nSMase activity in S. thermophilus. Extracts from S.
thermophilus (at indicated amounts) were reacted at pH 7.4 with labeled
SM vesicles in the presence of protease and phosphatase inhibitors, β-
glycerophosphate, ATP, and Mg. Hydrolyzed SM was quantitated and
expressed as pmol per min. The results are expressed as mean values from
three experiments in duplicate. SEM values were ever lower than 5% of
mean values.
determination of ceramide levels with the DAG kinase assay.
Decreasing amounts of bacteria (2.5, 1.25, and 0.625 mg) were
incubated in the presence or absence of a constant amount of
unlabeled SM (200 pmol) for 2 h with appropriate buffers to assay
nSMase or aSMase. The results reported in Fig 2, indicating the
ceramide generation from pure SM incubated with S. thermophilus
confirmed the presence of high levels of nSMase in our bacterial
samples. Relevant amounts of both nonhydroxyceramides and
hydroxyceramides were generated accordingly with the fatty acid
species present in the natural SM molecule. Indeed, even if the
predominant fatty acids present in SM are C16:0/C24:0 fatty acids,
hydroxylated forms of fatty acids are frequently found (reviewed
in Merrill and Jones, 1990; Riboni et al, 1997). On the other hand,
no ceramide generation was observed in samples that lacked added
SM (Fig 2A), in accordance with the lack of SM in prokaryotic
plasma membranes (Yeagle, 1993). Also with this experimental
approach there was no evidence of aSMase in bacterial sonicates
(not shown).
Effects of S. thermophilus on keratinocyte ceramide levels To investigate
the effect of S. thermophilus on ceramide levels of keratinocytes
in vitro, we treated the cells at different times (0.25–18 h) with a
preparation of bacteria, previously sonicated as described in Materials
and Methods. The treatment of the subconfluent keratinocyte
cultures with S. thermophilus resulted in a significant increase of
ceramide generation, as detected by TLC analysis of phospho-
lipids extracted from cells and subjected to DAG kinase assay; Fig 3
shows the total ceramide levels expressed as mean values of pmol
ceramides per 100 µg protein from three experiments in duplicate.
Ceramide generation strongly and gradually increased in the pres-
ence of sonicated S. thermophilus in a time-dependent manner,
being already evident at 15 min and reaching highest levels at 18 h
(a 3–5-fold increase with respect to the control value at 18 h).
Accordingly, with the previously reported ability of keratinocytes
to generate ceramide constitutively (Schurer et al, 1989; Holleran
et al, 1990; Madison et al, 1990), the basal level of ceramides present
in the untreated cells also increased during the culture, even if to
a lesser extent (12–14-fold increase at 18 h with respect to the
basal value) with respect to the treated keratinocytes (50–60-fold
increase at 18 h, with respect to the basal value). The increase of
ceramide levels in keratinocytes (5 3 106 cells per 10 ml) treated
with sonicated bacteria interested both hydroxyceramides and
Figure 2. SM-derived ceramide generation through nSMase from S.
thermophilus. Extracts from S. thermophilus at different amounts (a, 2.5 mg;
b, 2.5 mg; c, 1.25 mg; d, 0.625 mg) were incubated in Tris/HCl buffer
at pH 7.4 with protease and phosphatase inhibitors, β-glycerophosphate,
ATP, and Mg, in the absence (a) or presence (b–d) of exogenous unlabeled
SM vesicles. Lipids were then extracted and subjected to DAG-kinase
assay for ceramide determination. Radioactive spots were visualized by
autoradiography, scraped from the plate and counted by scintillation. (A)
The results from one representative experiment are shown (autoradiography
of TLC plate (A, hydroxyceramides; B, nonhydroxyceramides). (B)
Ceramide generation derived from SM hydrolysis was quantitated and
expressed as mean values from three experiments in duplicate. SEM values
were ever lower than 10% of the mean value.
nonhydroxyceramides, as shown in the representative experiment
reported in Fig 4(A). The incubation of sonicated S. thermophilus
for 18 h led to a significant increase of both hydroxyceramide and
nonhydroxyceramide levels. Similar results were obtained in two
other experiments and the quantitative data (mean values from
three experiments in duplicate) are shown in Fig 4(B).
Effects of S. thermophilus on keratinocyte SM levels To characterize
the enzymes responsible for the above reported ceramide generation
induced by S. thermophilus, we first analyzed the SM hydrolysis in
cells after treatment with sonicated bacteria for 18 h. Subconfluent
keratinocytes, previously labeled with [N-methyl-14C]choline for
48 h, were treated with sonicated S. thermophilus for 18 h, as
described in Materials and Methods. Cellular lipids were then
extracted and analyzed by TLC. Figure 5 shows that the treatment
with S. thermophilus resulted in an almost total hydrolysis of
radiolabeled SM, whereas the other labeled compounds (i.e.,
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Figure 3. Kinetics of ceramide generation in keratinocytes after
treatment in vitro with S. thermophilus. Cells (5 3 106 per 10 ml) were
treated for the indicated times with a sonicated S. thermophilus suspension
(50 mg per 10 ml, final concentration). Lipids were then extracted and
subjected to DAG kinase assay for ceramide determination. Radioactive
spots were visualized by autoradiography, scraped from the plate and
counted by scintillation counting. Mean values from three experiments in
duplicate are shown. SEM values were ever lower than 10% of the
mean value.
phosphatidylcholine and lyso-phosphatidylcholine) did not signi-
ficantly change. Comparable levels of SM hydrolysis were observed
by treating the cells for 2 h with exogenous authentic B. cereus
nSMase, 100 mU per ml (not shown). Thus, ceramide generation
observed after treatment with S. thermophilus could be attributed,
at least partially, to the hydrolysis of keratinocyte SM.
Effects of S. thermophilus on keratinocyte ceramide synthase activity The
possibility that the S. thermophilus-induced ceramide level increase
in keratinocytes could also be due to the activation of ceramide
synthase, was assessed. This enzyme, also known as sphinganine
N-acyl transferase (Merrill and Jones, 1990), catalyzes the condensa-
tion of sphinganine and fatty acyl-coenzyme A to form dihydrocera-
mide, which is rapidly oxidized to form ceramide. As previously
reported (Schurer et al, 1989; Holleran et al, 1990; Madison et al,
1990), this pathway appeared to be constitutively activated in
control keratinocytes and could account for the relatively high and
gradually increasing basal ceramide levels in our experimental
conditions and during the analyzed time interval
(0–18 h) (Fig 6). As shown, the incubation of keratinocytes in the
presence of sonicated S. thermophilus did not significantly influence
ceramide synthase activity, thus indicating that the S. thermophilus-
induced ceramide increase described above could not be attributable
to a stimulation of this pathway.
Effect of S. thermophilus on keratinocyte cholesterol levels The possibil-
ity that S. thermophilus extracts could also influence cholesterol
levels in cultured keratinocytes was assessed. Cholesterol levels
from cells previously incubated in the absence or presence of S.
thermophilus extracts for 1, 6, or 18 h were analyzed and no significant
difference between untreated or treated samples was observed.
In vivo studies
Effects of S. thermophilus on stratum corneum ceramide levels In order
to determine whether the effects of S. thermophilus observed in vitro
on cultured keratinocytes could also be obtained in vivo, we
analyzed the skin ceramide levels obtained from lipid extracts from
the forearms of 17 volunteers, after a 7 d treatment either with the
Figure 4. Induction of both hydroxyceramide and non-
hydroxyceramide generation in keratinocytes after treatment with
S. thermophilus. Cells (5 3 106 per 10 ml) were treated for 18 h with a
sonicated S. thermophilus suspension (50 mg per 10 ml, final concentration).
Lipids were then extracted and subjected to DAG kinase assay for ceramide
determination. Radioactive spots were visualized by autoradiography,
scraped from the plate and counted by scintillation counting. (A) The
results from one representative experiment are shown (autoradiography of
TLC plate (A, hydroxyceramides; B, nonhydroxyceramides). Lane a:
untreated keratinocytes; lane b: keratinocytes treated with S. thermophilus
for 18 h. (B) Mean values from three experiments in duplicate are shown.
SEM values were always lower than 10% of the mean value.
base cream or the same cream plus sonicated S. thermophilus. Total
stratum corneum ceramide levels, which showed a strong basal
subjective variability (range: 0.25–198 pmol total ceramides per µg
protein; mean 6 SEM: 36 6 14 pmol total ceramides per µg
protein), were significantly increased in almost all subjects following
treatment with the base cream alone (mean 6 SEM: 136 6 25 pmol
ceramides per µg protein; T1 versus T0, p , 0.001) (Fig 7A). This
effect was significantly less relevant when compared with the
experimental cream treatment (mean 6 SEM: 639 6 136.21 pmol
ceramides per µg protein; T1 versus T0, p , 0.001) (Fig 7B).
Moreover, to show directly that the changes we described in the
in vivo experiments were caused by the presence of nSMase in S.
thermophilus extracts, the effects of the topical application of the
same base cream containing authentic nSMase from B. cereus instead
of S. thermophilus extracts, were analyzed in four volunteers (2, 7,
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Figure 5. Sphingomyelin hydrolysis induction in keratinocytes after
treatment with S. thermophilus. Cells (5 3 106 per 10 ml) were labeled
for 48 h with [N-methyl-C]choline, then treated for 18 h with a sonicated
S. thermophilus suspension (50 mg per 10 ml, final concentration). Lipids
were then extracted and subjected to TLC to resolve lyso-phosphatidyl-
choline, SM, and phosphatidylcholine. Radioactive spots were visualized
by autoradiography, scraped from the plate and counted by scintillation
counting. (A) Autoradiography of a TLC plate from a representative
experiment. Lane a, untreated cells; lane b, keratinocytes treated with S.
thermophilus for 18 h. (B) Mean values from three experiments in duplicate
are shown. SEM values were always lower than 15% of the mean value.
12, and 17). The results, reported in Fig 7(C), indicate also that
this treatment was able to determine in all subjects a very significant
increase of skin ceramide levels, which was comparable with that
observed after topical application of S. thermophilus-containing
cream. Figure 8 shows some representative autoradiographies of
skin ceramide levels obtained before (T0) and after (T1) the base
(lane a) or experimental cream treatment (lane b).
As regards the possibility that the vehicle base cream or the
experimental cream contain SM or ceramides, we analyzed the
levels of these lipids and no evidence of their presence was obtained
(not shown). Therefore, the possibility of such contaminating lipids
in the crude homogenates which could substantially alter the SM/
ceramide content of cells of the stratum corneum when added
exogenously, could be excluded. Interestingly, the inhibition of
Figure 6. Kinetics of ceramide synthase activity in keratinocytes
after treatment with S. thermophilus. Extracts from keratinocytes (5 3 106
per 10 ml), treated for the indicated times with a sonicated S. thermophilus
suspension (50 mg per 10 ml, final concentration) were subjected to
ceramide synthase activity assay for 1 h, as described in Materials and
Methods. Lipids were then extracted using chloroform/methanol (1/2).
Ceramides were resolved using TLC, detected by comigration with
ceramide standards. Radioactive spots were visualized by autoradiography,
scraped from the plate and counted by scintillation counting. Ceramide
generation was quantitated and expressed as mean values from two
experiments in duplicate. SEM values were always lower than 10% of the
mean value.
bacterial nSMase with GSH, almost totally prevented (70%–90%
inhibition) the ceramide increase that was induced by topical
application of either the S. thermophilus extract-containing cream
(Fig 9A) or B. cereus nSMase-containing cream (Fig 9B). In
Fig 9(C) two representative autoradiographies of skin ceramide
levels are reported from one subject (12) before (T0) and after (T1)
treatment for 7 d with the experimental creams and with or
without GSH.
DISCUSSION
This study was conducted to determine the effect of sonicated S.
thermophilus on the levels of ceramides either in vitro in a human
keratinocyte cell line (HaCaT) or in vivo on the forearm skin of
17 healthy volunteers.
Our results show a very relevant ceramide increase in keratino-
cytes in vitro after culture with S. thermophilus. Both hydroxyceram-
ide and nonhydroxyceramide levels strongly and gradually increased
in the presence of sonicated S. thermophilus in a time-dependent
manner, being evident as early as 15 min and reaching highest
levels at 18 h. The increase of ceramide levels could be due to SM
hydrolysis observed in keratinocytes previously labeled with an SM
precursor. The SM hydrolysis could be correlated with the high
levels of a neutral GSH-sensitive SMase detected in S. thermophilus.
No detectable aSMase activity could be observed in these bacteria.
Our results exclude the possibility that the increase of ceramide
levels induced in keratinocytes after the treatment with sonicated
S. thermophilus, was due to a synthesis de novo of ceramide through
the ceramide synthase activity, as this pathway, basically activated
in these cells (Schurer et al, 1989; Madison et al, 1990; Holleran
et al, 1990), was not influenced by the presence of sonicated bacteria.
The possibility that S. thermophilus extracts could also influence
cholesterol levels in cultured keratinocytes was investigated. The
obtained results indicate that bacterial extracts present in the cultures
for 1, 6, or 18 h did not influence cholesterol levels in these cells.
The in vitro results were confirmed by in vivo studies in 17
healthy and young volunteers. A relevant increase in stratum
corneum ceramide levels was indeed observed in all analyzed
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Figure 7. Effects of S. thermophilus on stratum corneum ceramide
levels. Skin lipid extracts from the forearms of 17 healthy volunteers
before (T0) and after (T1) treatment for 7 d with the base cream (A) or
with the experimental cream containing sonicated S. thermophilus (B) were
analyzed for ceramide level determination through DAG kinase assay. (C)
The effects of the topical application of a purified B. cereus nSMase-
containing cream on four volunteers.
subjects after the 7 d topical application of a vehicle base cream
containing lysed S. termophilus. Also in these in vivo experiments,
the topical treatment with S. thermophilus induced a very significant
increase of ceramide levels. An increase of ceramide content, even
if very less relevant, was also observed after treatment with the
vehicle base cream. This result could be explained with the presence
in the latter of different oils rich in fatty acids which could in turn
be utilized for the ceramide biosynthetic pathway (Bose et al, 1995).
Nevertheless, we cannot exclude other possible mechanisms. We
can hypothesize that damage to the barrier caused by lipid solvents
used in this work to extract stratum corneum lipids could have led
Figure 8. Four representative autoradiographies of TLC. Autoradio-
graphies of TLC of hydroxyceramides (A) and nonhydroxyceramides (B)
extracted from forearm stratum corneum of four individuals (relative
numbers are indicated) before (T0) and after (T1) treatment for 7 d with
the base cream (a) or with the experimental cream containing sonicated
S. thermophilus (b).
to an increase of epidermal lipidogenesis and fatty acid synthesis
proportional to the degree of barrier disruption; also when the
hyperpermeability was corrected with the base cream, the lipido-
genesis returned to normal values, in accordance with previous
investigations which stressed the relationship between barrier func-
tion and lipid synthesis (Grubauer et al 1985; Menon et al, 1985).
Ceramides predominantly present in stratum corneum consist of
C16–C22 sphingosine and dihydrosphingosine bases amidated to
long chain fatty acids, which may or may not be hydroxylated and
unsaturated (Rawlings et al, 1994). Ceramides generated after
treatment with S. thermophilus extracts are both hydroxy-fatty acid
ceramides and nonhydroxy fatty acid ceramides. Both these types
of ceramides exert important functions for epidermal homeostasis,
e.g., permeability barrier function of the skin, as previously reported
(Motta et al, 1994; Rawlings et al, 1994; Murata et al, 1996). The
results obtained with keratinocytes in vitro strongly suggest that
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Figure 9. Effect of GSH on the ceramide level increase induced
in vivo by the treatment with a purified B. cereus nSMase-containing
or S. thermophilus extract-containing creams. Skin lipid extracts from
the forearms of four healthy volunteers before (T0) and after (T1) treatment
for 7 d with the experimental creams containing sonicated S. thermophilus
(A) or purified B. cereus nSMase (B) were analyzed for ceramide level
determination through DAG kinase. assay. (C) Two representative auto-
radiographies of TLC of (A, hydroxyceramides; B, nonhydroxyceramides)
extracted from forearm stratum corneum of one subject (12) before (T0)
and after (T1) treatment for 7 d with experimental creams with or
without GSH.
S. thermophilus nSMase could be also responsible for the observed
ceramide increase in vivo. The presence of high levels of nSMase
in this micro-organism, indicated by assaying the enzymatic activities
in vitro, appears to be responsible for the observed increase in
stratum corneum ceramide levels. Indeed, a comparable skin
ceramide level increase was also observed after the topical application
of a cream containing purified B. cereus nSMase. In addition, the
finding that the inhibition of bacterial nSMase activity through
GSH pretreatment, blocked this effect further supports the idea
that nSMase is causing the skin ceramide changes observed in vivo.
It is unlikely that the observed effect was due to contaminating
factors potentially present in the bacterial preparations. Bacterial
nSMase has been used for many experimental studies on apoptosis
in several cell systems (Bettaieb et al, 1996; Wright et al, 1996;
Flamigni et al, 1997; Zhang et al, 1997), which showed that the
enzymatic preparations were able to induce a specific hydrolysis of
SM with consequent ceramide generation. Moreover, it seems
difficult to hypothesize that the same ‘‘putative contaminating
factor’’ could be present either in the S. thermophilus or in the
B. cereus preparations. These bacteria are strongly different: S.
thermophilus is a non pathogenic gram-positive lactic acid bacterium
and B. cereus is a pathogenic β-hemolytic gram-positive, aerobe
spore-forming rod, able to release several toxins which contribute
to its virulence. Finally, it is a remote possibility that a putative
contaminant factor present in both bacterial preparations could also
be glutathione-sensitive.
The route by which the enzyme is penetrating into viable
epidermis and gains access to keratinocytes and intracellular organ-
elles is not clear. The lipids for epidermal permeability barrier
function are stored in the epidermal lamellar bodies (Freinkel and
Traczyk, 1985; Grayson et al, 1985; Elias et al, 1988; Holleran et al,
1993; Madison and Howard, 1996). Among several other lipids,
SM may be also present in the external surface of the lamellar body
membranes. These organelles represent the delivery mechanism for
most lipid catabolic enzymes and their lipid substrates to the stratum
corneum interstices. Moreover, SM is also present in the intercellular
domains at the level of the stratum corneum, even if in a small
quantity. Exogenous bacterial nSMase could hydrolyze all these
different pools of SM thus generating ceramides. The sonication
procedure of the bacterial extracts leading to micelle formation
together with the presence of absorption enhancers (i.e., poly-
ethylene glycol), oils, and protease inhibitors in the vehicle base
cream, capable of reducing the barrier resistance (Verhoef et al,
1990; Murakami et al, 1998), could favor enzyme access and skin
penetration. On the other hand, the transfollicular pathway could
constitute a preferential route of penetration for nSMase-containing
micelles, as previously reported for the uptake of molecules such
as γ-interferon from human skin upon the application of liposomal
formulation (Du Plessis et al, 1992).
Altogether, our findings have potential clinical significance. First,
the increase in ceramide content may be extremely beneficial to
the commonly xerotic skin of the aged. Second, the improvement
in the integrity of the barrier implies a reduced susceptibility to
the insults of the environment (e.g., decreased humidity, solvents,
and detergents), as well as an increased capacity to recover from
environmental insults. Third, the induction of an increased ceramide
level through S. termophilus, could represent a useful, simple and
inexpensive pharmacologic approach in those pathologic conditions
associated with a general reduction in skin lipid content, particularly
ceramide. With regard to this, the possible restoration of ceramide
content in the skin of patients suffering from desquamatory diseases
(i.e., psoriasis), after topical treatment with creams containing
sonicated S. thermophilus, is already under investigation.
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